Compositions and methods for treating phenylketonuria
US-2024141381-A1 · May 2, 2024 · US
Vibrio anguillarum bacteriophage VIB-ANP-1 and use thereof for inhibiting proliferation of Vibrio anguillarum bacteria
US11439677B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11439677-B2 |
| Application number | US-201716329931-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 21, 2017 |
| Priority date | Sep 2, 2016 |
| Publication date | Sep 13, 2022 |
| Grant date | Sep 13, 2022 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention relates to Siphoviridae bacteriophage Vib-ANP-1(accession number KCTC 13075BP) having the ability to specifically kill Vibrio anguillarum bacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention or treatment of Vibrio anguillarum bacterial infection by using a composition containing the same bacteriophage as an effective ingredient.
First claim
Opening claim text (preview).
The invention claimed is: 1. A feed additive composition comprising maltodextrin and 1×10 4 pfu/ml to 1×10 15 pfu/ml or 1×10 4 pfu/g to 1×10 15 pfu/g of Siphoviridae bacteriophage Vib-ANP-1 that has a specific antibacterial activity against Vibrio anguillarum and a 213.97 kb size of genome expressed by a nucleotide sequence of SEQ ID NO:1, and is deposited as accession number of KCTC 13075BP. 2. The feed additive composition of claim 1 , wherein the composition suppresses diseases caused by Vibrio anguillarum , or alleviates the pathological condition of the diseases caused by Vibrio anguillarum. 3. A method for suppressing diseases caused by Vibrio anguillarum , or alleviating the pathological condition of the diseases caused by Vibrio anguillarum , wherein the method comprises a step of administering to an animal other than a human a composition comprising maltodextrin and 1×10 4 pfu/ml to 1×10 15 pfu/ml or 1×10 4 pfu/g to 1×10 15 pfu/g of Siphoviridae bacteriophage Vib-ANP-1 (Accession number: KCTC 13075BP), that has a specific antibacterial activity against Vibrio anguillarum and a 213.97 kb size of genome encoded by the nucleotide sequence of SEQ ID NO:1.
Assignees
Inventors
Classifications
Uses of virus other than therapeutic or vaccine, e.g. disinfectant · CPC title
- A61K35/76Primary
Viruses; Subviral particles; Bacteriophages · CPC title
- C12N7/00Primary
Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00) · CPC title
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
Nucleic acids; Hydrolysis products or derivatives thereof · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11439677B2 cover?
- The present invention relates to Siphoviridae bacteriophage Vib-ANP-1(accession number KCTC 13075BP) having the ability to specifically kill Vibrio anguillarum bacteria and a genome represented by SEQ ID NO: 1 and isolated from nature, and a method for prevention or treatment of Vibrio anguillarum bacterial infection by using a composition containing the same bacteriophage as an effective ingre…
- Who is the assignee on this patent?
- Intron Biotechnology Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K35/76. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Sep 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).